A 48-year-old man in Winnipeg who says his right leg was to be amputated due to an infection came out of the medical ...

Aethlon Medical has enrolled the first patient in its Australian clinical trial evaluating the safety, feasibility, and ...

Palvella Therapeutics announced the first patient has been dosed in SELVA, a multicenter, Phase 3 clinical trial designed to evaluate the ...

Canadian clinical trial company Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of ...

New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient’s diagnosis, leads to ...

ORGO earnings call for the period ending September 30, 2024. Organogenesis ( ORGO -1.43%) Q3 2024 Earnings Call Nov 12, 2024, ...

We expect to enroll the first patient in the study in the first quarter of 2025 ... And I think it also speaks to certepetide's benign safety profile that while we hope it has significant impact on ...

Research about whether CBD improves fibromyalgia symptoms is sparse. However, read on to learn about existing evidence and ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

Stereotaxis said Genesis delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias.

A new operator was recently tapped to run the hospital, which for months has struggled to provide care as its cash-crunched owner Steward Health Care tried to thin billions in debt after filing for ...